Literature DB >> 8990663

The effects of therapy with rifampicin and isoniazid on basic investigations for Cushing's syndrome.

T H Zawawi1, M S al-Hadramy, S M Abdelwahab.   

Abstract

Rifampicin(R) is a potent enzyme inducer which is now widely used to treat many conditions. We have investigated its effect on adrenal function tests in 18 adults with tuberculosis on rifampicin (R) and isoniazid (INH) as in-patients. Midnight cortisol was above 250 nmol/l in 11 patients with a mean +/- (SD) of 340 +/- 193 nmol/l. The morning serum cortisol following 1 and 4 mg dexamethasone overnight was abnormal in 88.9 per cent and 83.3 per cent respectively. The respective mean values +/- (SD) were 350 +/- 179 and 336 +/- 279 nmol/l. The mean 24-hour urinary free cortisol +/- SD was 513 +/- 375 nmol and was above normal in 6 (33.3 per cent) patients. These results show that midnight cortisol, dexamethasone suppression tests and 24-hour urinary free cortisol are misleading in patients with tuberculosis on (R) and should not be employed for investigating such patients for Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8990663     DOI: 10.1007/bf02943098

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  15 in total

1.  Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.

Authors:  T Mengden; P Hubmann; J Müller; P Greminger; W Vetter
Journal:  Clin Investig       Date:  1992-07

Review 2.  Enzyme induction in the cytochrome P-450 system.

Authors:  A B Okey
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 3.  Cortisol assays: guidelines for the provision of a clinical biochemistry service.

Authors:  A Moore; R Aitken; C Burke; S Gaskell; G Groom; G Holder; C Selby; P Wood
Journal:  Ann Clin Biochem       Date:  1985-09       Impact factor: 2.057

4.  Effect of diphenylhydantoin on the metabolism of dexamethasone.

Authors:  W Jubiz; A W Meikle; R A Levinson; S Mizutani; C D West; F H Tyler
Journal:  N Engl J Med       Date:  1970-07-02       Impact factor: 91.245

5.  [A comparative study of the accelerated metabolism of cortisol, prednisolone and dexamethasone in patients under rifampicin therapy].

Authors:  S Kawai
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1985-03-20

6.  The effect of different doses of rifampicin on thyroid hormone metabolism [proceedings].

Authors:  E E Ohnhaus; H Studer
Journal:  Br J Clin Pharmacol       Date:  1980-03       Impact factor: 4.335

Review 7.  Cushing's syndrome.

Authors:  T A Howlett; L H Rees; G M Besser
Journal:  Clin Endocrinol Metab       Date:  1985-11

8.  Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy.

Authors:  V Kyriazopoulou; A G Vagenakis
Journal:  J Clin Endocrinol Metab       Date:  1992-07       Impact factor: 5.958

9.  Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.

Authors:  A W Meikle
Journal:  Clin Endocrinol (Oxf)       Date:  1982-04       Impact factor: 3.478

10.  Alterations in thyroid hormones, cortisol, and catecholamine concentration in patients after orthopedic surgery.

Authors:  A H Juma; M S Ardawi; T M Baksh; A A Serafi
Journal:  J Surg Res       Date:  1991-02       Impact factor: 2.192

View more
  5 in total

Review 1.  Nuclear receptor PXR, transcriptional circuits and metabolic relevance.

Authors:  Chibueze A Ihunnah; Mengxi Jiang; Wen Xie
Journal:  Biochim Biophys Acta       Date:  2011-02-02

Review 2.  Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolism.

Authors:  Jinhan He; Qiuqiong Cheng; Wen Xie
Journal:  Mol Endocrinol       Date:  2009-09-17

Review 3.  Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.

Authors:  Hongbing Wang; Edward L LeCluyse
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  SXR, a novel steroid and xenobiotic-sensing nuclear receptor.

Authors:  B Blumberg; W Sabbagh; H Juguilon; J Bolado; C M van Meter; E S Ong; R M Evans
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

Review 5.  Biology of PXR: role in drug-hormone interactions.

Authors:  Jing Wang; Shu Dai; Yan Guo; Wen Xie; Yonggong Zhai
Journal:  EXCLI J       Date:  2014-07-07       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.